Table 2.

The IC₅₀ (μM) and relative potency per active unit (rp/n) for 1–6 obtained with ASF-competitive ELISA assay ^a.

	Ligand 1	Ligand 2	Ligand 3	Ligand 4	Ligand 5	Ligand 6
Gal-1	78 ± 23	19 ± 5	9 ± 3	0.086 ± 0.05	0.41 ± 0.08	0.082 ± 0.02
rp/n	1	2	2.8	906	95	317
Gal-3	44 ± 8	12 ± 2	4.4 ± 1.6	11 ± 1	4.6 ± 1.3	1.7 ± 0.4
rp/n	1	1.8	3.3	4	4.8	8.6

^a The data were adopted from our previous work [24].